Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vericel Corporation - Common Stock
(NQ:
VCEL
)
34.81
+0.32 (+0.93%)
Streaming Delayed Price
Updated: 12:42 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vericel Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth
↗
May 09, 2026
Via
Chartmill
Vericel Q1 Earnings Call Highlights
↗
May 09, 2026
Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage repair franchise and Burn Care business, as well as...
Via
MarketBeat
Topics
Earnings
Vericel (VCEL) Q1 2026 Earnings Transcript
↗
May 08, 2026
Vericel (VCEL) Q1 2026 Earnings Transcript
Via
The Motley Fool
Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge
↗
May 07, 2026
Via
Chartmill
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
May 07, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity
↗
May 05, 2026
Via
Chartmill
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick
↗
March 27, 2026
Via
Chartmill
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case
↗
February 27, 2026
Via
Chartmill
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability
↗
February 26, 2026
Via
Chartmill
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
From
Vericel Corporation
Via
GlobeNewswire
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
April 02, 2026
From
MediWound Ltd.
Via
GlobeNewswire
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
April 02, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
March 04, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp (NASDAQ:VCEL) Presents a Strong Growth and Breakout Setup
↗
February 06, 2026
Via
Chartmill
Vericel Corp (NASDAQ:VCEL) Emerges as a Prime GARP Investment Candidate
↗
February 03, 2026
Via
Chartmill
VERICEL CORP (NASDAQ:VCEL) Fits the "Growth at a Reasonable Price" Profile
↗
January 01, 2026
Via
Chartmill
Vericel to Present at Multiple Upcoming Investor Conferences
March 03, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel (VCEL) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Vericel (VCEL) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
From
Vericel Corporation
Via
GlobeNewswire
Why Is Vericel Stock Gaining Tuesday?
↗
January 13, 2026
Vericel Corporation (NASDAQ: VCEL) stock rose on Tuesday after announcing preliminary financial results for 2025.
Via
Benzinga
Vericel Announces Preliminary 2025 Financial Results and Business Updates
January 13, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
January 06, 2026
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp. (NASDAQ:VCEL) Presents a High-Growth Profile with a Technical Setup for a Potential Breakout
↗
December 15, 2025
Vericel Corp. (VCEL) combines strong revenue growth and accelerating earnings with a technical setup suggesting a potential price breakout from a key support level.
Via
Chartmill
Vericel Corp (NASDAQ:VCEL) Emerges as a Top GARP Investment Candidate
↗
December 11, 2025
Vericel Corp (VCEL) exemplifies GARP investing with strong growth, high profitability, and a valuation reasonable for its biotech sector.
Via
Chartmill
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
November 14, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Candidate
↗
November 12, 2025
Vericel (VCEL) offers affordable growth in biotech with strong revenue & earnings, solid financials, and a reasonable valuation relative to peers.
Via
Chartmill
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
↗
November 06, 2025
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
Via
The Motley Fool
Topics
Regulatory Compliance
Vericel (VCEL) Q3 2025 Earnings Call Transcript
↗
November 06, 2025
Vericel (VCEL) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Vericel Corporation (NASDAQ:VCEL) Surpasses Earnings Estimates with Strong Q3 2025 Results
↗
November 06, 2025
Vericel (VCEL) beats Q3 2025 earnings estimates with strong revenue growth and a swing to profitability, driven by its MACI and burn care products.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
